SEI Investments
YMAB

SEI Investments’s Y-mAbs Therapeutics YMAB Stock Holding History

SEI Investments’s Portfolio YMAB Stock Details YMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-32,950
Closed -$534K – 2671
2021
Q4 		$534K Buy
32,950
+7,859
+31% +$168K ﹤0.01% 2078
2021
Q3 		$716K Buy
25,091
+5,140
+26% +$162K ﹤0.01% 1912
2021
Q2 		$674K Buy
19,951
+850
+4% +$27.3K ﹤0.01% 1954
2021
Q1 		$578K Buy
19,101
+3,315
+21% +$136K ﹤0.01% 1962
2020
Q4 		$782K Buy
15,786
+6,204
+65% +$287K ﹤0.01% 1795
2020
Q3 		$368K Buy
9,582
+1,159
+14% +$46.1K ﹤0.01% 2023
2020
Q2 		$364K Sell
8,423
-240
-3% -$9.08K ﹤0.01% 1992
2020
Q1 		$226K Buy
+8,663
New +$252K ﹤0.01% 2066

Other funds holding YMAB

AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

SEI Investments's YMAB Position: Q1 2022 in Review

SEI Investments sold out of Y-mAbs Therapeutics (YMAB) in Q1 2022, closing a stake of 32,950 shares — an estimated $534K sold.

SEI Investments first reported a position in YMAB in Q1 2020 and held it in 8 quarters. The position peaked at $782K in Q4 2020. 88 funds tracked by Wall St. Rank hold YMAB as of Q1 2022.

  • SEI Investments reported no remaining Y-mAbs Therapeutics position as of Q1 2022 after selling out during the quarter.
  • SEI Investments sold 32,950 Y-mAbs Therapeutics shares in Q1 2022, an estimated $534K.
  • SEI Investments first reported a position in Y-mAbs Therapeutics in Q1 2020 and held it in 8 quarters.
  • SEI Investments's Y-mAbs Therapeutics position peaked at $782K in Q4 2020.
  • 88 funds tracked by Wall St. Rank held Y-mAbs Therapeutics as of Q1 2022.

Based on SEI Investments's 13F filing for Q1 2022, filed 13 May 2022.